A detailed history of Burt Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Burt Wealth Advisors holds 1,966 shares of ABBV stock, worth $349,967. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,966
Previous 1,972 0.3%
Holding current value
$349,967
Previous $338,000 14.79%
% of portfolio
0.1%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $983 - $1,195
-6 Reduced 0.3%
1,966 $388,000
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $2,321 - $2,711
-15 Reduced 0.75%
1,972 $338,000
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $73,197 - $83,401
-458 Reduced 18.73%
1,987 $361,000
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $10,420 - $12,062
-78 Reduced 3.09%
2,445 $364,000
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $38,957 - $48,480
-294 Reduced 10.44%
2,523 $339,000
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $16,485 - $18,985
114 Added 4.22%
2,817 $448,000
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $28,630 - $34,335
-207 Reduced 7.11%
2,703 $437,000
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $134 - $153
1 Added 0.03%
2,910 $391,000
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $39,594 - $49,125
300 Added 11.5%
2,909 $472,000
Q1 2021

Apr 15, 2021

SELL
$102.3 - $112.62 $20,050 - $22,073
-196 Reduced 6.99%
2,609 $282,000
Q2 2020

Aug 05, 2020

SELL
$73.37 - $98.18 $2,274 - $3,043
-31 Reduced 1.09%
2,805 $275,000
Q2 2019

Aug 05, 2019

SELL
$65.7 - $83.98 $42,376 - $54,167
-645 Reduced 18.53%
2,836 $206,000
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $25,301 - $31,203
325 Added 10.3%
3,481 $321,000
Q1 2018

Apr 24, 2018

SELL
$92.01 - $123.21 $13,801 - $18,481
-150 Reduced 4.54%
3,156 $299,000
Q4 2017

Jan 30, 2018

BUY
$89.56 - $98.21 $17,912 - $19,642
200 Added 6.44%
3,306 $320,000
Q2 2017

Aug 07, 2017

BUY
N/A
3,106
3,106 $225,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Burt Wealth Advisors Portfolio

Follow Burt Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burt Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Burt Wealth Advisors with notifications on news.